跳至主要内容
临床试验/NCT01511887
NCT01511887已完成不适用

Evaluation of the Safety and Efficacy of Oral Ibuprofen in Term 20-28 Days Old Newborns Referred to Bandar Abbass Children Hospital in 2011

Hormozgan University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2011年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
PDA closure after 1 week

研究概览

简要总结

The aim of current study is to evaluate the efficacy and safety of oral Ibuprofen in term 20-28 days old newborn referred to Bandarabbas children' hospital in 2011.

详细描述

Patent Ductus Arteriosus (PDA) accounts for about 10% of Congenital Heart Disease. Surgical treatment in PDA is associated with higher rate of complication than pharmacologic treatment. Efficacy of Ibuprofen is shown in preterm and low birth weights newborn with PDA. Studies in term neonates after the first days of birth are rare. The aim of current study is to evaluate the efficacy and safety of oral Ibuprofen in term 20-28 days old newborn referred to Bandarabbas children' hospital in 2011.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Days 至 28 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Term newborn (37 weeks of gestation or more)
  • Age between 20-28 days
  • confirmed diagnosis of PDA by echocardiography by pediatric cardiologist

排除标准

  • Hemorrhage
  • Platelet count < 150000
  • renal or gastrointestinal malformations
  • associated congenital heart disease

研究组 & 干预措施

Oral Ibuprofen

Experimental

10mg/kg oral ibuprofen followed by two 5mg/kg in 12 hours intervals. If there was no improvement after first cycle of treatment this treatment was repeated.

干预措施: Oral Ibuprofen (Drug)

结局指标

主要结局

PDA closure after 1 week

时间窗: 1 weeks after treatment

PDA closure after 1 week of treatment based on echocardiography

PDA closure after two weeks

时间窗: 2 weeks after treatment

PDA closure two weeks after treatment based on echocardiography

次要结局

  • Drug side effects(two weeks after treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hamidreza Mahboobi

Principal Investigator

Hormozgan University of Medical Sciences

研究点 (1)

Loading locations...

相似试验

Safety and Efficacy of Ibuprofen in Term Newborns... | 临床试验